Tamer Mehanna

Tamer Mehanna is the CEO and Co-Founder of Intaego. Tamer has over 20 years of experience in the business intelligence field. Tamer was previously with CVS Health for 10 years, where they were responsible for conducting primary and secondary market research for an innovative public-private partnership model that secured the highest ever market access for Zyprexa, Lilly’s $4.5 billion flagship neuroscience product. Tamer also spent two years at Massachusetts General Hospital, where they conducted research on cognitive modeling of neurogenesis in the brain structures where memory is encoded for improvement of cognitive function in patients with Alzheimer's disease.

Tamer Mehanna has a Bachelor's degree in Biomedical Engineering from Boston University. Tamer also has a Master of Business Administration from INSEAD and The Wharton School. Tamer also has a Doctor of Pharmacy from Massachusetts College of Pharmacy and Health Sciences. Tamer Mehanna is also certified from FINRA in Series 3 and 65.

Some individuals on their team include Kawthar Bouachrine - Head of Marketing & Co-founder, Simeon Gatev - Head of Operations & Co-founder.